Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | PPIA | P62937 | 1/20 | 0.42 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.41 |
| ▸ | ITGB7 | P26010 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27875249 | 0.83 | RAB9A (0.49) | RAB9ANPC1TDP1ATMPPIA | |
| SCHEMBL31489148 | 0.83 | CA12 (0.44) | RAB9ANPC1 | |
| SCHEMBL31489162 | 0.77 | MAPT (0.46) | RAB9ANPC1TDP1ATM | |
| SCHEMBL30059309 | 0.76 | LMNA (0.49) | RAB9ANPC1TDP1 | |
| SCHEMBL38659346 | 0.75 | NPC1 (0.43) | RAB9ANPC1ATM | |
| SCHEMBL87044 | 0.75 | POLB (0.61) | RAB9ANPC1PPIA | |
| SCHEMBL28821026 | 0.74 | CA12 (0.50) | RAB9ANPC1 | |
| SCHEMBL20564912 | 0.74 | ALDH1A1 (0.49) | RAB9ANPC1ATM | |
| SCHEMBL6966891 | 0.74 | PLAU (0.59) | RAB9ANPC1HDAC1HDAC2 | |
| SCHEMBL23671289 | 0.73 | LMNA (0.47) | RAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025072437-A1 | HETEROARYL COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS | ALPHINA THERAPEUTICS, INC. (US) | 2025-04-03 | — | — | WO | disclosed |